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Abstract
Chemokine-mediated directed tumor cell migration within a three dimensional (3D) matrix, or chemoinvasion, is an
important early step in cancer metastasis. Despite its clinical importance, it is largely unknown how cytokine and growth
factor gradients within the tumor microenvironment regulate chemoinvasion. We studied tumor cell chemoinvasion in well-
defined and stable chemical gradients using a robust 3D microfluidic model. We used CXCL12 (also known as SDF-1a) and
epidermal growth factor (EGF), two well-known extracellular signaling molecules that co-exist in the tumor
microenvironment (e.g. lymph nodes or intravasation sites), and a malignant breast tumor cell line, MDA-MB-231,
embedded in type I collagen. When subjected to SDF-1a gradients alone, MDA-MB-231 cells migrated up the gradient, and
the measured chemosensitivity (defined as the average cell velocity along the direction of the gradient) followed the ligand
– receptor (SDF-1a – CXCR4) binding kinetics. On the other hand, when subjected to EGF gradients alone, tumor cells
increased their overall motility, but without statistically significant chemotactic (directed) migration, in contrast to previous
reports using 2D chemotaxis assays. Interestingly, we found that the chemoinvasive behavior to SDF-1a gradients was
abrogated or even reversed in the presence of uniform concentrations of EGF; however, the presence of SDF-1a and EGF
together modulated tumor cell motility cooperatively. These findings demonstrate the capabilities of our microfluidic model
in re-creating complex microenvironments for cells, and the importance of cooperative roles of multiple cytokine and
growth factor gradients in regulating cell migration in 3D environments.
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Introduction
Tumor cell chemoinvasion within a 3D tissue, or chemoinva-
sion, is an important step in cancer metastasis [1,2,3]. Despite its
clinical importance, the way tumor cells respond to chemical
gradients within a complex microenvironment – particularly
where multiple chemokines and growth factors coexist – is largely
unknown [1,2,4]. Such gradients are the result of a highly complex
and dynamic tumor microenvironment [5,6] that consists of
multiple cell types (e.g. stromal and immune cells), a heteroge-
neous extracellular matrix (ECM), and mechanical stress gradients
that also drive interstitial flow [7]. Thus, to improve our
understanding of how multiple exogenous factors affect tumor
cell motility and chemoinvasion, robust in vitro models are needed
that allow well-defined chemical gradients to be rapidly established
and maintained across well-defined 3D cultures that are large
enough to observe sufficient numbers of cells, with sufficient
migration distances, to quantitatively evaluate the range of
behaviors typically seen with tumor cell populations. Here, we
asked how tumor cells respond to single vs. combined gradients of
known chemoattractants using a newly developed 3D microfluidic
culture model [8] with a more general goal of recreating a
microenvironment that suppresses tumor cell dissemination.
The tumor microenvironment is spatially and temporally
heterogeneous due to multiple chemokines and growth factors
secreted by infiltrating leukocytes and surrounding stromal cells as
well as by the tumor cells themselves [4,9,10]. Subsequently,
extracellular signaling molecules form gradients that are critically
regulated by infiltrating cells, interstitial fluid flow, and gradients
in extracellular matrix density. Diffusion anisotropy and proteo-
lytic degradation have been discussed in the current literature
extensively [7,11]. Amongst the chemoattractant signaling mole-
cules that are known to be involved in tumor cell chemotaxis,
CXCR4 (which binds stromal derived growth factor (SDF-1a or
CXCL12) and EGFR (epidermal growth factor receptor) are
notable in their relevance to the metastasis in many different
cancer types, particularly breast cancer [4]. In Boyden chamber
assays, human breast tumor cells have been shown to chemotact
up gradients of both EGF [12,13] and SDF-1a [14,15].
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Furthermore, EGFR signaling is well-known to enhance tumor cell
motility [16,17].
Still, researchers are only beginning to explore tumor cell
invasion in more complex microenvironments [4,18] such as those
that exist not only in the primary tumor stroma but also niche sites
for disseminated cells such as bone marrow or lymph nodes [6].
Furthermore, EGF-secreting macrophages were shown to be
recruited to tumor-associated blood vessels that secrete SDF-1a
from pericytes in a rat breast cancer model [19,20]. Since such
signaling pathways may have synergistic or antagonistic interac-
tions, if any, it is important to build models and methods for
qualitatively understanding cell response to complex environ-
ments, which is ultimately needed in future efforts aimed at
building a predictive model for chemoinvasion in cancer [1].
Limitations of current models widely used to study chemotaxis
or chemoinvasion, such as Boyden chambers, include (i) the lack of
precise gradients that are stable in space or time [21], (ii) the lack
of ability to differentiate chemotaxis from chemokinesis (i.e.,
enhancement of random motility but not directedness, which is
less efficient for cell transport) [4,11], and (iii) endpoint quality of
the assay, which does not allow imaging during migration and thus
misses information on the dynamics, distribution, and cell
morphology during cell migration. Microfluidic chemoinvasion
models have recently been introduced to overcome these
limitations and create more physiologically relevant models
[11,22,23,24,25,26]. Additionally, current cancer cell chemotaxis
studies using microfluidic models are largely limited to 2D, where
cells are plated on a 2D substrate [27,28]. 2D tumor cell
chemotaxis is fundamentally different from that of 3D. In 2D,
MDA-MB-231 cells use a mesenchymal migration strategy only
because it requires integrin activities (or adhesion). In 3D,
mammalian cells can either squeeze through the pores of the
biomatrix via amoeboid motion or climb along the collagen fibers
via mesenchymal motion. In the case of leukocytes in steady state
conditions, cells have been found to move within collagen fibers
via amoeboid motion and independent of integrin binding [29].
MDA-MB-231 cells have been shown to undergo mesenchymal-
to-amoeboid transition when pericellular proteolysis is blocked
[30].
In this study, we examine how tumor cell chemoinvasion
behaviors can be affected by two competing chemical gradients,
using a 3D microfluidic model with well-defined chemical
gradients that are stable in space and time. A highly invasive
and metastatic human breast cancer cell line, MDA-MB-231, was
used because of the extent of characterization of this cell line [14],
including its migration behavior in the presence of EGF or SDF-
1a gradients using conventional Boyden chamber [12,14,31].
Additionally, the methodologies presented here are readily
applicable to other tumor cells or to more complex tumor
microenvironments.
Materials and Methods
Microfluidic Chemoinvasion Device Design and
Characterization
A microfluidic chemoinvasion device previously developed in
our lab was modified for this experiment [8,32]. Chemoinvasion
here is defined as tumor cell migration within 3D biomatrices
under the influences of chemokines and growth factors. Briefly,
four three – parallel – channel devices were patterned on a 1 mm
thick agarose gel membrane using a silicon master. The agarose
gel membrane was then placed on a 1 inch61 inch glass slide and
was sandwiched between a Plexiglas manifold and a stainless metal
frame in a biohood. The operation principles are shown in the
schematics in Figure 1B. Briefly, chemokine and buffer flow
through two side channels respectively, and a linear chemokine
gradient is established in the center channel via diffusion of
chemokine molecules though the agarose ridges. The time for the
gradient establishment depends on the diffusion coefficient of the
molecules. For EGF (6.2 kDa) or SDF-1a (8.0 kDa), the molecular
diffusion coefficient is about 111 mm2/s [33], it takes about 30 min
to establish a steady gradient. To characterize the chemical
gradients in the center channel of the device, we flow fluorescein-
labeled dextran (0.1 mM, MW=10 kDa, Invitrogen) and buffer
through the two side channels, and then take the time-lapse
fluorescence images of all three channels. The fluorescence
intensity profile cross all three channels are used to represent the
chemical concentration gradients (For more details please see ref.
[8]).
3D Cell Culture
A malignant breast cancer cell line, MDA-MB-231, was
obtained as a gift from the Cornell University Center on the
Microenvironment and Metastasis. The basal medium for the cell
line was DMEM (Invitrogen, Carlsbad, CA), supplemented with
10% FBS (Atlanta Biologicals, Lawrenceville, GA) and antibiotics
(100 units penicillin and 100 mg streptomycin, Invitrogen). Cell
cultures were maintained every 2–3 days at a T75 flask (Corning,
Lowell, MA) with 5,10% of initial confluency (percentage of cell
area coverage) in a humidified, CO2-controlled incubator at 37uC.
SDF-1a (10 mg/ml in PBS with 0.1% BSA) and EGF (200 mg/ml
in 20 mM acetic acid) were purchased from R&D Systems
(Minneapolis, MN) and stored at 220uC after reconstitution as
instructed by the suppliers.
Type I collagen was extracted from rat tails (Pel-Freez, Rogers,
AR) using a modified protocol [34] and stored at 5 mg/ml in 0.1%
acetic acid at 4uC. Cell pellets from 50,75% confluency from
T75 cultures were re-suspended in DMEM with 10% FBS and
then mixed at 16106 cells/ml with 1N NaOH (for pH,7), 10X
M199 and 0.15% collagen on ice. Cell numbers were counted
using a hemocytometer (Bright-Line Hemocytometer, Hausser
Sci., Horsham, PA). For a typical composition for 500 ml mixture,
150 ml 5 mg/ml collagen, 50 ml 106M199, 3.3 ml 1N NaOH, and
296.7 ml cell culture at 1 million/mL cell concentration were
mixed.
Gel Filling and Device Setup
A volume of 20 ml of cell embedded collagen was introduced
into the middle channel of each of the 4 devices using a gel-loading
tip. All the inlets and outlets are plugged for preventing slow flow
in the center channels during polymerization process. To
polymerize the collagen gel, the device was placed in a 37uC
incubator for at least 20 minutes of which the device was placed
upside down for the first 7 minutes for better distributing cells in
the z-direction. Cell distribution in 3D was visually confirmed
using a bright field microscope (Nikon Eclipse TS100, Nikon
Instruments, Melville, NY) right after the gelation (See Figure 1).
Cells were incubated for 24 hours in the device so that cells will
have time to attach to the matrix. We start imaging the cells at the
same time when the chemical/buffer were introduced in the two
side channels where we define t = 0. For a typical experiment, one
device was used as a control where media were pumped through
both side channels. Flows of three different chemical concentra-
tions and buffers were introduced to the other three source and
sink channels respectively. The flows ran at a rate of 1 ml/min
through a medical grade tubing (ID= 0.51 mm, PharMed BPT,
Cole-Parmer, Vernon Hills, IL) using a syringe pump (KDS230,
Roles of Two Cytokines in Tumor Cell Migration
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KD Scientific, Holliston, MA) and a syringe (3 ml, BD, Franklin
Lakes, NJ).
Imaging and Data Analysis
For live cell imaging, the device was transferred onto an
environmentally controlled microscope stage. The device was
surrounded by a small Plexiglas chamber
(120 mm675 mm645 mm) set at 37uC, 100% humidity and
5% CO2 (CO2-200, In Vivo Scientific, World Precision Instru-
ments, Inc., Sarasota, FL). The microscope stage were surrounded
by a temperature controlled chamber (Weather Station, Precision
Control LLC) set at 37uC. For each experiment, we typically
imaged 8 positions (2 on each device, with 4 devices on one chip)
using the x-y controlled stage (OptiScan II, Prior Scientific, Inc.,
Rockland, MA). The images were captured every 5 minutes for 16
hours using the bright field microscopy (206objective, Olympus
IX81, Center Valley, PA), an image acquisition software Slide-
Book (Intelligent Imaging Innovations, Inc., Denver, CO) and a
CCD camera (Orca-ER, Hamamatsu, Bridgewater, NJ). For the
data reported here, we imaged one plane close to the center of the
channel in the vertical direction. These experiments were repeated
at least once.
Cell trajectories were obtained first using a Manual Tracker in
ImageJ (National Institutes of Health) from the time series images
as shown in Figure 1D. Cell speed U ’ (length of the trajectories
divided by time), the velocity Vx
’ (displacement along the gradient
direction divided by time), cell persistence length P’ (the
displacement of a cell trajectory divided by the length of the
trajectory), and the cell persistence length along gradient direction
Px
’ (the displacement of a cell trajectory along the gradient
direction divided by the length of the trajectory) were then
computed from the cell trajectories of 16 hour duration (See
Figure 2E) using an in house Matlab program (The MathWorks,
Inc., Natick, MA). Here, only motile cells (U ’.0.2 mm/min) were
included for further data analysis, which usually accounted for
,50% of the total cell population. The average speed, velocity and
persistence length were computed from about 120 or more cells
under the same chemical gradient, which usually come from at
least two separate experiments. To minimize the experiment-to-
experiment variation, speed U is normalized by the average speed
of the control cells (no chemical gradients), and velocity along the
direction of gradient, Vx, is computed as the average velocity
along x-direction subtracted by that of the control group, and
divided by the average speed of the control. Persistence length P is
normalized by the average persistence length of the control group.
Persistence length along the gradient direction Px is normalized by
subtracting that of the control group. Nonparametric t-test
compared to the control group (Mann-Whitney test) within Prism
(GraphPad Software, Inc., La Jolla, CA) was used for statistical
analysis.
Results and Discussion
Microfluidic Device Setup, 3D Cell Culture and Dynamic
Cell Tracking
Chemical gradients were generated using a recently developed
microfluidic device (Fig. 1A–B) [8,24]. Briefly, three parallel
channels were patterned on a 1 mm thin agarose gel membrane.
Medium containing either SDF-1a, EGF, or neither was
introduced to each of two side channels, and allowed to form
gradients by diffusion across the agarose gel ridges between the
channels. Cell-seeded type I collagen was introduced into the
center channel. This device has been recently characterized for its
ability to generate stable and well-defined gradients both
computationally and experimentally using FITC conjugated
proteins [8,24], which was used to explore dendritic cell
chemotaxis previously [8,24]. Various chemical gradients were
generated in the center channel by changing the chemical
concentrations in the source and sink channels. The chemical
gradient is calculated as the difference of the chemical concentra-
tions in sink and source channels divided by the distance between
the source and sink channels (i.e. 900 mm). The average chemical
concentration is computed as the average of the chemical
concentrations in sink and the source channels. A uniform
Figure 1. Microfluidic device setup and data acquisition. A. An
image of the microfluidic device on the microscope stage. A penny is
placed on the side for scale. B. Schematic illustration of the microfluidic
device. Three parallel channels are patterned on a 1-mm thick agarose
gel membrane. A stable linear gradient is generated across the center
channel by flowing solutions of chemokine and buffer through the
source and the sink channels respectively. A mixture of cells (1 million
cells/ml) embedded in type I collagen (1.5 mg/ml) is seeded in the
center channel. All three channels are 400 mm wide and 250 mm deep,
and the ridges between the channels are 250 mm wide. C. 3D
reconstruction of a z-stack of 65 images (5 mm each) of the cell-
embedded collagen matrix viewed from x-y plane (top view) and the x-z
plane (side view); scale bar, 50 mm. D. Cell trajectory plots (60 cells
each) from the four conditions indicated. In the last panel, the uniform
0.25 nM EGF is generated by supplying 0.25 nM EGF solutions along
the two side channels. Each colored line represents one cell trajectory
tracked in 16 h.
doi:10.1371/journal.pone.0068422.g001
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concentration in the center channel is generated by supplying the
same chemical concentration solution in both side channels.
The 3D cell culture consisted of 106 tumor cells/ml embedded
in type I collagen extracted from rat tail [34]. Different
concentrations (0.15, 0.25 and 0.35%) of collagen were compared,
and we measured the average cell speed to be 0.4260.02,
0.3060.02, and 0.2660.02 mm/min, respectively. We therefore
used 1.5 mg/ml collagen for all the experiments shown here. In
our culture model, cells remained evenly distributed after collagen
polymerization (Fig. 1C) in part aided by inverting the device
upside-down during the first 7 min of collagen polymerization [8].
In vitro collagen matrices are substantially different than those
in vivo, specifically being more simple in composition, less dense
in collagen, and more spatially homogeneous. A high collagen
density (similar to that of breast tumor in vivo) cannot be used
for in vitro assays, since tumor cell migration is suppressed by the
dense and spatially homogenous biomatrix network. However, it
has been shown that the in vivo tumor microenvironment is
highly heterogeneic in terms of spatial distribution of the
collagen fibers. Multiphoton imaging of breast tumor cell
migration in mouse model shows that fast and persistent tumor
cell migration is often associated with three factors – the lack of
dense collagen network, amoeboid motion, and the contact of
cells with ECM fibers [35,36]. It is thus important to place
tumor cells in the context of a collagen matrix for in vitro
studies, and processes like tumor cell chemoinvasion can be
mimicked with close proximity to the in vivo situation in such
matrices [24,29,37].
Cell movements were characterized in real time and space by
taking a time sequence of images of migrating cells, and
Figure 2. Plasticity and heterogeneity of tumor cell morphology and motility behavior. A–B. Bright field images of MDA-MB-231 cells
embedded in 3D collagen matrices within the microfluidic channel at t = 0 and 8 h. Here, t = 0 is defined as the time when buffer and 100 nM SDF-1a
solution were introduced into the two side channels. Cells were pre-incubated for 24 hours after seeding before the introduction of the gradients. C.
Graphical description of cell speed U ’, cell velocity along the gradient direction Vx ’, persistence length P’, and gradient-directed persistence length
Px
’. D. Graphical description of aspect ratio. Distribution of cell aspect ratios at t = 0 and 8 h. E. Distribution of cell speed of elongated cells (aspect
ratio larger than 3) and amoeboid-like cells (aspect ratio less than 3).
doi:10.1371/journal.pone.0068422.g002
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subsequently tracking the cell positions at various time points.
Examples of cell tracking process are shown in Movie S1 and
Movie S2. Figure 1D shows cell trajectories of 16 h duration
under four different chemical gradient conditions. These polar
plots were formed by placing the first cell position of each cell
track at the center coordinate. It should be noted that although
the experiments were conducted in 3D, the cell tracking was
carried out using images taken at a fixed 2D (or x–y) plane.
Figure 1D shows that tumor cells migrated randomly under
control conditions (no chemical gradients), were chemoinvasive
towards SDF-1a gradients, and displayed chemokinesis (or
enhanced motility) in the presence of EGF gradients as well
as in the presence of both EGF and SDF-1a gradients.
Plasticity of Tumor Cell Morphology and Migration
Behavior under Changing Microenvironments
The morphology and migration of the MDA-MB-231 cells were
followed when flows were introduced to the two side channels.
When MDA-MB-231 cells were initially cultured in type I collagen
matrix for 24 hours with no flow along the two side channels, the
majority of motile cells exhibited a typical elongated (or
mesenchymal-like) morphology, in contrast to a more rounded
(or amoeboid-like) morphology (See Figure 2A,B). Initially, about
50% of motile cells had aspect ratios less than 3. After 8 hours
flowing buffer or chemokine through the two side channels, the
majority of motile cells (,80%) had aspect ratios less than 3 (See
Figure 2B, D). Figure 2D shows that the aspect ratio of the cells
decreased with time. Note that we exclude the potential stress
under the microscope based on the observations that cells are
motile as shown in Movie S1 and Movie S2. In addition, we found
that i) the cells without flow in the side channels maintained a high
aspect ratio in the microscope stage; and ii) the majority of the cells
with flow in the side channels for the initial culture period (24 h) in
a conventional incubator showed a similar decrease in the aspect
ratio.
Tumor Cell Chemoinvasion in SDF-1a Gradients Follows
the Ligand – Receptor Binding Kinetics
Figure 3A shows the average cell velocity along the gradient
Vx as a function of SDF-1a gradient. Note that Vx peaks at
SDF-1a gradient of 111 nM/mm. Early work from our groups
[24] and others [38] have shown that immune cell chemoinva-
sion follows a ligand – receptor kinetics, indicating that cell
chemoinvasion is governed by the difference of the ligand –
receptor bound states at the front and rear of the cell.
Therefore, we fitted the Vx versus SDF-1a gradient data to the
ligand – receptor association kinetic equation, more specifically
the difference of the ligand – receptor bound states at the front
Figure 3. Chemoinvasive and chemokinetic behavior of tumor cells to linear SDF-1a gradients. A. Average cell velocity Vx along the
SDF-1a gradient as a function of the SDF-1a gradient +C. Solid line is a fit to the ligand – receptor binding kinetics Vx~A +C
CavgzKDð Þ2
 
. B. Average
cell speed as a function of the SDF-1a concentration gradient. C. Average persistence length along the gradient direction Px as a function of SDF-1a
concentration gradient. D. Average persistence length P as a function of SDF-1a concentration gradient. The stars were obtained using a
nonparametric t-test compared to the control group (Mann-Whitney test with * for 0.01,p,0.05, ** for 0.001,p,0.01, and *** for p,0.001).
doi:10.1371/journal.pone.0068422.g003
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and rear of the cell, Vx~A
+C
(CavgzKD)
2, where A is a constant
and C is the SDF-1a concentration (See Figure 3A). The fitted
data provides a ligand – receptor association constant
KD = (59.2638.3) nM. This agrees well with the reported
literature value of KD = (55615) nM, where the kinetic
association constant of SDF-1a and CXCR4 was measured
using an elegant fluorescence resonance energy transfer (FRET)
method [39,40].
Tumor Cells Display Mild Chemokinesis in SDF-1a
Gradients
We first looked at the fraction of migrating cells (defined as
cell speed .0.2 mm/min), and observed no visible changes,
0.6460.05 for control vs. 0.6260.04 for 111 nM/mm SDF-1a.
We then plotted the average cell speed under various SDF-1a
gradients. Figure 3B shows that cells have no significant speed
increase when SDF-1a gradient was less than 56 nM/mm (or
an average SDF-1a concentration of 25 nM) and an increase of
speed, about 7–13%, when SDF-1a gradient was equal or
greater than 56 nM/mm. Measurements of persistence lengths
along6direction also demonstrate the chemotactic behavior of
tumor cells along the SDF-1a gradients (Figure 3C). It is
interesting to note that the persistence length was significantly
higher (20–40%) at low SDF-1a gradients (less or equal to
56 nM/mm) (Figure 3D).
Tumor Cells Showed no Significant Chemoinvasion, but
Mild Chemokinesis in EGF Gradients
The Vx versus EGF gradients plot in Figure 4A shows that no
statistically significant chemoinvasion behavior were observed
under four different EGF gradients; in contrast to previous report
that EGF is a chemo-attractant for human breast tumor cells
(MDA-MB-231) using Boyden chamber assays [12,41], Dunn
Chamber (a 2D assay where cells are plated on a substrate) [42]
and rat breast tumor cells [43]. Cell average speed has an increase
of about 8–12% for EGF gradient of 0.56, 5.56 and 18.52 nM/
mm or average EGF concentration of 0.25, 2.5 and 8.33 nM. This
is consistent with previous report that a small fraction (2–5%) of
the EGF receptors display a high EGF-binding affinity (KD =10–
100 pM), whereas the majority of the receptors (95–98%) display a
lowered association constant (KD =2–5 nM) obtained by a
125I
labeled EGF binding assay [44,45]. It should also be noted that
EGFR is known to internalize in the presence of ligand binding,
which may also contribute to the behavior observed in Figure 4B
[46].
The difference of our chemoinvasion results in EGF gradients to
those reported in the literature using Boyden chamber is likely
caused by the fact that (i) Boyden chambers do not distinguish
chemotaxis versus chemokinesis [12,41]; (ii) 2D chemotaxis is
fundamentally different from 3D chemoinvasion [28,42]. In 2D,
cells exhibit large focal adhesion complexes, and their migration
Figure 4. Tumor cells display no chemoinvasion but mild chemokinesis in linear EGF gradients. Average cell velocity Vx along the EGF
gradient (A), average cell speed U (B), average persistence length along the EGF concentration gradient Px (C) and average persistence length P (D)
as a function of EGF gradients. The stars were obtained using a nonparametric t-test compared to the control group (Mann-Whitney test with * for
0.01,p,0.05, ** for 0.001,p,0.01, and *** for p,0.001).
doi:10.1371/journal.pone.0068422.g004
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behavior depend critically on the integrin binding sites. In 3D,
motile MDA-MB-231 cells displayed mostly amoeboid-like (or
rounded) cell morphology (See Figure 2), and they migrated by
squeezing through the collagen fiber pores. For leukocytes in
steady-state conditions, amoeboid cell migration within a 3D
environment has been found to be integrin-independent [29]. It
has also been reported that the organization of focal adhesion
proteins may be different in 2D vs. 3D conditions [47]. Further
studies controlling integrin expression will be needed to elucidate
the differential roles of integrin in 2D versus 3D chemoinvasion.
Using a 2D microfluidic model, it was reported that EGF
gradient steepness played a critical role in MDA-MB-231 cell
chemotaxis [28]. Although it is difficult to compare the results
from a 3D microfluidic model here directly with those of a 2D
model, we do not exclude the possibility that a steeper EGF
gradient may stimulate a chemotactic response. The gradient
shapes could be critical in the case of aggregating receptor systems
such as EGFR, suggesting that the difference in fractional receptor
activation is more important than the difference in fractional
receptor occupancy [48].
The persistence length along the gradient direction Px was
decreased in the presence of EGF gradients (Figure 4C), while the
persistence length P under various EGF gradients (Figure 4D) did
not display a general pattern, it decreased at an EGF gradient of
0.56 nM/mm (or average concentration of 0.25 nM), and
increased at EGF gradient of 18.2 nM/mm (or average concen-
tration of 8.33 nM).
Uniform Background of EGF Abrogates Chemoinvasion
of MDA-MB-231 Cells in SDF-1a Gradients; EGF and SDF-
1a Cooperatively Modulate MDA-MB-231 Cell Motility
Surprisingly, we found that tumor cell chemoinvasion up a
gradient of SDF-1a (111 nM/mm) was abrogated by the presence
of a uniform background of 0.25 nM EGF (Fig. 5A). Furthermore,
when EGF concentration was increased to 8.33 nM, tumor cells
actually displayed chemorepulsive behavior to the SDF-1a
gradient (Fig. 5A).
Previous work using a 2D microfluidic model demonstrated that
exogenous EGF is required for facilitating MDA-MB-231 cell
chemotaxis in SDF-1a gradients [27]. We argue that the difference
of our observation and their work comes from three factors. (i) 2D
cell migration is fundamentally different from 3D cell migration as
stated above; (ii) Autocrine signals are washed away in the flow
based 2D device, while they retained in the diffusion based 3D
device. It has been demonstrated that autocrine EGF influences
the persistence of epithelial cell migration [49]; (iii) Flow based 2D
device provides steeper and nonlinear gradient profile, while the
diffusion based 3D device provides linear gradient profile.
Figure 5B shows that EGF and SDF-1a cooperatively modulate
cell motility. Here we show the average cell speed under the same
chemical gradient condition as those shown in Figure 5A. With
EGF (0.25 nM) alone, the cell speed increased,9%; with SDF-1a
gradient (111 nM/mm) and EGF background (0.25 nM average
concentration), the cell speed increased ,30% in comparison to
the control group. Further increasing EGF concentration to
8.33 nM inhibited this phenomenon.
Figure 5C further demonstrate that EGF and SDF-1a
cooperatively modulates tumor cell motility. Here, a ,9% speed
increase is observed when the cells are in the presence of SDF-1a
only, and 11% increase when the cells are in the presence of EGF
only, but a ,30% increase when both SDF-1a and EGF are
present. It should be noted that this motility enhancement is
abrogated at high EGF concentration (8.3 nM) when all the
EGFR receptors are saturated.
Cross signaling between CXCR4 and EGFR has been found to
stimulate cancer cell growth previously [50], however its impact on
cancer cell migration in 3D microenvironment has not been
explored [18]. Results presented here demonstrate the capability
of a 3D microfluidic in vitro model in presenting complex chemical
gradients to cancer cells, and the importance of the cross signaling
between two important receptors CXCR4 and EGFR on tumor
cell dissemination.
In summary, we present experimental work on how breast
tumor cells (MDA-MB-231) were regulated by single or dual
gradients in 3D environment to drive directed invasion, which was
previously unknown. We demonstrated that tumor cell chemoin-
Figure 5. Cooperative roles of EGF and SDF-1a in tumor cell
chemoinvasion. Average cell velocity Vx (A) and speed U (B) in the
presence of a SDF-1a gradient of 111 nM/mm and a uniform EGF
concentration of 0, 0.25 or 8.33 nM. Control conditions were without
SDF-1a and EGF. C. Average cell speed under indicated conditions. The
stars were obtained using a nonparametric t-test compared to the
control group (Mann-Whitney test with * for 0.01,p,0.05, ** for
0.001,p,0.01, and *** for p,0.001).
doi:10.1371/journal.pone.0068422.g005
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vasion in SDF-1a (ligand to CXCR4) gradients follows a general
ligand – receptor binding dynamics, highlighting the importance
of the ligand – receptor association constant KD. Not only EGF
gradients alone do not cause chemoinvasion, the presence of EGF
background abrogate the chemoinvasive behavior of tumor cells in
SDF-1a gradients; in contrast to the observations in a 2D
environment [18,42]. Cooperatively, EGF and SDF-1a modulates
tumor cell motility. This work highlights the importance of
studying tumor cell chemoinvasion within a physiologically
realistic, 3D, microenvironment, and provides a general frame-
work for future data driven theoretical modeling of the 3D tumor
cell chemoinvasion processes within a complex microenvironment.
Supporting Information
Movie S1 Tracking MDA-MB-231 cells for 16 hours in
control. Tumor cell morphology heterogeneity is shown in the
movie. No directed cell migration is observed in the control movie.
The channel width is 400 mm and the time between two
consecutive images is 8 minutes.
(AVI)
Movie S2 Tracking MDA-MB-231 cells for 16 hours
under a 56 nM/mm SDF-1a gradient. Tumor cell morphol-
ogy heterogeneity is shown in the movie. Chemotactic motion
towards the high concentration of SDF-1a (right-side) side is
observed. The channel width is 400 mm and the time between two
consecutive images is 8 minutes.
(AVI)
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